Global End Stage Renal Disease Treatment Market Report, History and Forecast 2016-2027
Summary
Market Analysis and Insights: Global End Stage Renal Disease Treatment Market
The research report studies the End Stage Renal Disease Treatment market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global End Stage Renal Disease Treatment market size was value at US$ 52,230.17 million in 2021 and is forecast to be a readjusted size of US$ 76,138.00 million by 2028 with a CAGR of 5.46% during the forecast period 2022-2028.
Global End Stage Renal Disease Treatment Scope and Segment
The global End Stage Renal Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global End Stage Renal Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Middle East & Africa
Egypt
Saudi Arabia
UAE
- 1 MARKET OVERVIEW OF END STAGE RENAL DISEASE TREATMENT
- 1.1 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW
- 1.1.1 END STAGE RENAL DISEASE TREATMENT PRODUCT SCOPE
- 1.1.2 END STAGE RENAL DISEASE TREATMENT MARKET STATUS AND OUTLOOK
- 1.2 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE OVERVIEW BY REGION 2017 VS 2021 VS 2028
- 1.3 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY REGION (2017-2028)
- 1.4 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY REGION (2017-2022)
- 1.5 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE FORECAST BY REGION (2023-2028)
- 1.6 KEY REGIONS END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 1.6.1 NORTH AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 1.6.2 EUROPE END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 1.6.3 ASIA-PACIFIC END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 1.6.4 LATIN AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 1.6.5 MIDDLE EAST & AFRICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
- 2 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW BY TYPE
- 2.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY TYPE: 2017 VS 2021 VS 2028
- 2.2 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY TYPE (2017-2022)
- 2.3 GLOBAL END STAGE RENAL DISEASE TREATMENT FORECASTED MARKET SIZE BY TYPE (2023-2028)
- 2.4 HEMODIALYSIS
- 2.5 PERITONEAL DIALYSIS
- 2.6 KIDNEY TRANSPLANTATION
- 3 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW BY APPLICATION
- 3.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY APPLICATION: 2017 VS 2021 VS 2028
- 3.2 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 3.3 GLOBAL END STAGE RENAL DISEASE TREATMENT FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
- 3.4 HOSPITALS
- 3.5 KIDNEY DIALYSIS CENTERS
- 3.6 AT HOME
- 3.7 OTHERS
- 4 END STAGE RENAL DISEASE TREATMENT COMPETITION ANALYSIS BY PLAYERS
- 4.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY PLAYERS (2017-2022)
- 4.2 GLOBAL TOP PLAYERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN END STAGE RENAL DISEASE TREATMENT AS OF 2021)
- 4.3 DATE OF KEY PLAYERS ENTER INTO END STAGE RENAL DISEASE TREATMENT MARKET
- 4.4 GLOBAL TOP PLAYERS END STAGE RENAL DISEASE TREATMENT HEADQUARTERS AND AREA SERVED
- 4.5 KEY PLAYERS END STAGE RENAL DISEASE TREATMENT PRODUCT SOLUTION AND SERVICE
- 4.6 COMPETITIVE STATUS
- 4.6.1 END STAGE RENAL DISEASE TREATMENT MARKET CONCENTRATION RATE
- 4.6.2 MERGERS & ACQUISITIONS, EXPANSION PLANS
- 5 COMPANY (TOP PLAYERS) PROFILES AND KEY DATA
- 5.1 FRESENIUS
- 5.1.1 FRESENIUS PROFILE
- 5.1.2 FRESENIUS MAIN BUSINESS
- 5.1.3 FRESENIUS END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.1.4 FRESENIUS END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.1.5 FRESENIUS RECENT DEVELOPMENTS
- 5.2 DAVITA
- 5.2.1 DAVITA PROFILE
- 5.2.2 DAVITA MAIN BUSINESS
- 5.2.3 DAVITA END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.2.4 DAVITA END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.2.5 DAVITA RECENT DEVELOPMENTS
- 5.3 BAXTER
- 5.3.1 BAXTER PROFILE
- 5.3.2 BAXTER MAIN BUSINESS
- 5.3.3 BAXTER END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.3.4 BAXTER END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.3.5 BAXTER RECENT DEVELOPMENTS
- 5.4 NIPRO
- 5.4.1 NIPRO PROFILE
- 5.4.2 NIPRO MAIN BUSINESS
- 5.4.3 NIPRO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.4.4 NIPRO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.4.5 NIPRO RECENT DEVELOPMENTS
- 5.5 B. BRAUN
- 5.5.1 B. BRAUN PROFILE
- 5.5.2 B. BRAUN MAIN BUSINESS
- 5.5.3 B. BRAUN END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.5.4 B. BRAUN END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.5.5 B. BRAUN RECENT DEVELOPMENTS
- 5.6 ASAHI KASEI
- 5.6.1 ASAHI KASEI PROFILE
- 5.6.2 ASAHI KASEI MAIN BUSINESS
- 5.6.3 ASAHI KASEI END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.6.4 ASAHI KASEI END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.6.5 ASAHI KASEI RECENT DEVELOPMENTS
- 5.7 NIKKISO
- 5.7.1 NIKKISO PROFILE
- 5.7.2 NIKKISO MAIN BUSINESS
- 5.7.3 NIKKISO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.7.4 NIKKISO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.7.5 NIKKISO RECENT DEVELOPMENTS
- 5.8 WEGO
- 5.8.1 WEGO PROFILE
- 5.8.2 WEGO MAIN BUSINESS
- 5.8.3 WEGO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.8.4 WEGO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.8.5 WEGO RECENT DEVELOPMENTS
- 5.9 NEWSOL
- 5.9.1 NEWSOL PROFILE
- 5.9.2 NEWSOL MAIN BUSINESS
- 5.9.3 NEWSOL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.9.4 NEWSOL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.9.5 NEWSOL RECENT DEVELOPMENTS
- 5.10 MAYO CLINIC
- 5.10.1 MAYO CLINIC PROFILE
- 5.10.2 MEDIONICS MAIN BUSINESS
- 5.10.3 MEDIONICS END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.10.4 MEDIONICS END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.10.5 MEDIONICS RECENT DEVELOPMENTS
- 5.11 GUANGDONG BIOLIGHT
- 5.11.1 GUANGDONG BIOLIGHT PROFILE
- 5.11.2 GUANGDONG BIOLIGHT MAIN BUSINESS
- 5.11.3 GUANGDONG BIOLIGHT END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.11.4 GUANGDONG BIOLIGHT END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.11.5 GUANGDONG BIOLIGHT RECENT DEVELOPMENTS
- 5.12 MEDTRONIC
- 5.12.1 MEDTRONIC PROFILE
- 5.12.2 MEDTRONIC MAIN BUSINESS
- 5.12.3 MEDTRONIC END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.12.4 MEDTRONIC END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.12.5 MEDTRONIC RECENT DEVELOPMENTS
- 5.13 SANXIN MEDTEC
- 5.13.1 SANXIN MEDTEC PROFILE
- 5.13.2 SANXIN MEDTEC MAIN BUSINESS
- 5.13.3 SANXIN MEDTEC END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.13.4 SANXIN MEDTEC END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.13.5 SANXIN MEDTEC RECENT DEVELOPMENTS
- 5.14 JAFRON BIOMEDICAL
- 5.14.1 JAFRON BIOMEDICAL PROFILE
- 5.14.2 JAFRON BIOMEDICAL MAIN BUSINESS
- 5.14.3 JAFRON BIOMEDICAL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.14.4 JAFRON BIOMEDICAL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.14.5 JAFRON BIOMEDICAL RECENT DEVELOPMENTS
- 5.15 SWS HEMODIALYSIS CARE
- 5.15.1 SWS HEMODIALYSIS CARE PROFILE
- 5.15.2 SWS HEMODIALYSIS CARE MAIN BUSINESS
- 5.15.3 SWS HEMODIALYSIS CARE END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.15.4 SWS HEMODIALYSIS CARE END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.15.5 SWS HEMODIALYSIS CARE RECENT DEVELOPMENTS
- 5.16 TIANYI MEDICAL
- 5.16.1 TIANYI MEDICAL PROFILE
- 5.16.2 TIANYI MEDICAL MAIN BUSINESS
- 5.16.3 TIANYI MEDICAL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
- 5.16.4 TIANYI MEDICAL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
- 5.16.5 TIANYI MEDICAL RECENT DEVELOPMENTS
- 6 NORTH AMERICA
- 6.1 NORTH AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
- 6.2 UNITED STATES
- 6.3 CANADA
- 7 EUROPE
- 7.1 EUROPE END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
- 7.2 GERMANY
- 7.3 FRANCE
- 7.4 U.K.
- 7.5 ITALY
- 7.6 RUSSIA
- 8 ASIA-PACIFIC
- 8.1 ASIA-PACIFIC END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY REGION (2017-2028)
- 8.2 CHINA
- 8.3 JAPAN
- 8.4 SOUTH KOREA
- 8.5 SOUTHEAST ASIA
- 8.6 INDIA
- 8.7 AUSTRALIA
- 9 LATIN AMERICA
- 9.1 LATIN AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
- 9.2 MEXICO
- 9.3 BRAZIL
- 10 MIDDLE EAST & AFRICA
- 10.1 MIDDLE EAST & AFRICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY
- 10.2 SAUDI ARABIA
- 10.3 UAE
- 10.4 EGYPT
- 10.5 SOUTH AFRICA
- 11 GLOBAL ESRD PATIENTS POPULATION BY MAJOR REGIONS IN 2022
- 12 END STAGE RENAL DISEASE TREATMENT MARKET DYNAMICS
- 12.1 END STAGE RENAL DISEASE TREATMENT INDUSTRY TRENDS
- 12.2 END STAGE RENAL DISEASE TREATMENT MARKET DRIVERS
- 12.3 END STAGE RENAL DISEASE TREATMENT MARKET CHALLENGES
- 12.4 END STAGE RENAL DISEASE TREATMENT MARKET RESTRAINTS
- 13 RESEARCH FINDING/CONCLUSION
- 14 METHODOLOGY AND DATA SOURCE
- 14.1 METHODOLOGY/RESEARCH APPROACH
- 14.1.1 RESEARCH PROGRAMS/DESIGN
- 14.1.2 MARKET SIZE ESTIMATION
- 14.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 14.2 DATA SOURCE
- 14.2.1 SECONDARY SOURCES
- 14.2.2 PRIMARY SOURCES
- 14.3 AUTHOR LIST
- 14.4 DISCLAIMER
- List of Tables
- Table 1. Global Market End Stage Renal Disease Treatment Market Size (US$ Million) Comparison by Region: 2017 VS 2021 VS 2028
- Table 2. Global End Stage Renal Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
- Table 3. Global End Stage Renal Disease Treatment Market Size Share by Region (2017-2022)
- Table 4. Global End Stage Renal Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
- Table 5. Global End Stage Renal Disease Treatment Forecasted Market Size Share by Region (2023-2028)
- Table 6. Global End Stage Renal Disease Treatment Market Size (US$ Million) by Type: 2017 VS 2021 VS 2028
- Table 7. Global End Stage Renal Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
- Table 8. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2017-2022)
- Table 9. Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
- Table 10. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2023-2028)
- Table 11. Global End Stage Renal Disease Treatment Market Size by Application: (US$ Million) 2017 VS 2021 VS 2028
- Table 12. Global End Stage Renal Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
- Table 13. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2017-2022)
- Table 14. Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
- Table 15. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2023-2028)
- Table 16. Global End Stage Renal Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
- Table 17. Global End Stage Renal Disease Treatment Revenue Market Share by Players (2017-2022)
- Table 18. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Treatment as of 2021)
- Table 19. Date of Key Players Enter into End Stage Renal Disease Treatment Market
- Table 20. Global End Stage Renal Disease Treatment Top Players Headquarters and Area Served
- Table 21. End Stage Renal Disease Treatment Product Solution and Service
- Table 22. Global End Stage Renal Disease Treatment Players Market Concentration Ratio (CR5 and HHI)
- Table 23. Mergers & Acquisitions, Expansion Plans
- Table 24. Fresenius Basic Information List
- Table 25. Fresenius Description and Business Overview
- Table 26. Fresenius End Stage Renal Disease Treatment Products, Services and Solutions32
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook